Experience

Gilmartin Group LLC

• United States
• Financial Services
• 1 - 100 Employee

• Vice President

  • Jan 2023 - 1 year

  New York, New York, United States

• Associate Vice President

  • Dec 2021 - Jan 2023

  New York, New York, United States

• Associate

  • Sep 2021 - Dec 2021

  New York, New York, United States



Solebury Strategic Communications

• United States
• Financial Services
• 1 - 100 Employee

• Senior Associate

  • Jul 2021 - Sep 2021

  New York, New York, United States

• Associate

  • Jan 2021 - Jul 2021

  New York, New York, United States

• Analyst

  • Jun 2018 - Jan 2021

  Greater New York City Area



The Trout Group

• United States
• Biotechnology Research
• 1 - 100 Employee

• Summer Analyst

  • Jun 2017 - Aug 2017

  Greater New York City Area



Ladenburg Thalmann

• Financial Services
• 100 - 200 Employee

• Healthcare Investment Banking Summer Analyst

  • Jun 2016 - Aug 2016

  Greater New York City Area Responsible for capital markets and precedent M&A transaction analytics and execution efforts in equity transactions for a diversity of healthcare companies. Researched companies across the healthcare sector using the Bloomberg Terminal, company filings and presentations for potential M&A transactions. Selected transaction experience: • Biodel (NASDAQ:BIOD): acquisition of Albireo Limited, announced May 2016. Performed analysis of selected Initial Public Offering transactions… Show more Responsible for capital markets and precedent M&A transaction analytics and execution efforts in equity transactions for a diversity of healthcare companies. Researched companies across the healthcare sector using the Bloomberg Terminal, company filings and presentations for potential M&A transactions. Selected transaction experience: • Biodel (NASDAQ:BIOD): acquisition of Albireo Limited, announced May 2016. Performed analysis of selected Initial Public Offering transactions and of selected publicly traded companies and the editing of the Fairness Opinion Letter to Biodel’s Board of Directors. • Performed due diligence and attended drafting sessions for an Israeli-based company’s F-1 filing. • Xenetic Biosciences (OTCQB:XBIO): NASDAQ uplisting, announced May 2016. Performed due diligence and various analyses related to precedent uplisting transactions. Show less



The Trout Group

• United States
• Biotechnology Research
• 1 - 100 Employee

• Summer Intern

  • Jun 2015 - Aug 2015

  Greater New York City Area Managed the “The Energy Boost”, a newsletter, including general sector news, financing news, upcoming conferences, and notable changes in public equities in the sector. Used FactSet to analyze movement in the market. Created pitchbooks for potential clients in the life sciences and renewable energy space. Tracked opportunities with Microsoft Dynamics CRM. Attended client meetings and conference calls with both buy-side and sell-side members of the Investment… Show more Managed the “The Energy Boost”, a newsletter, including general sector news, financing news, upcoming conferences, and notable changes in public equities in the sector. Used FactSet to analyze movement in the market. Created pitchbooks for potential clients in the life sciences and renewable energy space. Tracked opportunities with Microsoft Dynamics CRM. Attended client meetings and conference calls with both buy-side and sell-side members of the Investment Banking community. Show less